Professor Maria Hawkins

A clinician scientist in precision radiotherapy aiming to personalise radiation treatments using biology and AI. Committed to improving outcome through clinical research investigating effects in normal tissue and novel agents, novel radiation combinations. 

I was an MRC Group leader, in Oxford Institute for Radiation Oncology, University of Oxford- 2012-2019 and now she is a Professor of Radiotherapy at University College London Sept 2019. I am the clinical director of CRUK City of London Radiation Centre of Excellence, and director of radiotherapy translational research at UCL/UCLH. As chief investigator of randomised clinical trials my research has determined standards of care internationally for patients with gastro-intestinal malignancies such as cholangiocarcinoma and anal cancer. Working with NHS England I have been leading the commissioning of stereotactic ablative radiotherapy for hepatocellular cancer and pelvic disease re-irradiation, and co-lead commissioning of ablative radiotherapy in oligometastatic disease. Currently I am evaluating the role of protons as a bridge to transplant in cholangiocarcinoma. I am currently testing in clinical trials, novel radiotherapy drug combinations ( CAR-T, adenovirus) including protons in cancers of unmet need (oesophagus pancreas, hepatobilliary) and developing AI driven models for improved biological personalization of radiotherapy.